Cue Biopharma, Inc. Financial Ratios
CUE|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score -7.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-100.6%
Profit Margin
-96.9%
Net Income / Revenue
Asset Turnover
0.65
Revenue / Total Assets
Equity Multiplier
1.60
Total Assets / Equity
Composite: -100.6% (reported: -100.6%)
Profitability
Liquidity
Current Ratio
2.74
Quick Ratio
2.74
Solvency
Interest Coverage
-216.87
Efficiency
Asset Turnover
0.65
Inventory Turnover
-
Days Sales Outstanding
74 days
As of FY2025 · SEC 10-K · Updated Jun 24, 2026
Earnings Quality
Accrual Ratio
-13.2%
+0.3pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.